Community Schedule

Enter at least 4 characters

2 results showing for: 'octreotide'

  1. Endocrine Therapy
Octreotide    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 177.
  • Inj 100 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595885
    • Subsidy $32.71
    • Measure / Qty per 5
  • Inj 50 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595907
    • Subsidy $30.64
    • Measure / Qty per 5
  • Inj 50 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. DBL Octreotide
    • Pharmacode2272822
    • Subsidy $56.87
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Octreotide MaxRx Unapproved medicine supplied under Section 29.
    • Pharmacode2396939
    • Subsidy $30.64
    • Measure / Qty per 5
  • Inj 100 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. DBL Octreotide
    • Pharmacode2272814
    • Subsidy $40.00
    • Measure / Qty per 5
  • Inj 500 mcg per ml, 1 ml ampoule
    • Brand Fully subsidised brand. Octreotide GH Unapproved medicine supplied under Section 29.
    • Pharmacode2595893
    • Subsidy $113.10
    • Measure / Qty per 5
  • Inj 500 mcg per ml, 1 ml vial
    • Brand Fully subsidised brand. DBL Octreotide
    • Pharmacode2272806
    • Subsidy $145.00
    • Measure / Qty per 5
    • Brand Fully subsidised brand. Octreotide (Sun) Unapproved medicine supplied under Section 29.
    • Pharmacode2586002
    • Subsidy $222.00
    • Measure / Qty per 5

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 92

  1. Endocrine Therapy
Octreotide long-acting    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 177.
- Special Authority SA2072 -- Retail pharmacy
  • Inj depot 10 mg prefilled syringe
    • Brand Fully subsidised brand. Sandostatin LAR
    • Pharmacode2150832
    • Subsidy $1772.50
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615320
    • Subsidy $439.97
    • Measure / Qty per 1
    (Sandostatin LAR Inj depot 10 mg prefilled syringe to be delisted 01 March 2022)
  • Inj depot 20 mg prefilled syringe
    • Brand Fully subsidised brand. Sandostatin LAR
    • Pharmacode2150840
    • Subsidy $2358.75
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615339
    • Subsidy $647.03
    • Measure / Qty per 1
    (Sandostatin LAR Inj depot 20 mg prefilled syringe to be delisted 01 March 2022)
  • Inj depot 30 mg prefilled syringe
    • Brand Fully subsidised brand. Sandostatin LAR
    • Pharmacode2150859
    • Subsidy $2951.25
    • Measure / Qty per 1
    • Brand Fully subsidised brand. Octreotide Depot Teva
    • Pharmacode2615347
    • Subsidy $718.55
    • Measure / Qty per 1
    (Sandostatin LAR Inj depot 30 mg prefilled syringe to be delisted 01 March 2022)
SA2072 - Octreotide long-acting

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 92

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.